with the increase in sale, and inventory increase Baht 19.25 million , because reserve of raw material for new product and work in process increase by increase in customer order and other current asset
can pass through most of the raw material’s price increase to customers. Our gross profit in terms of amount will not be affected, however, the selling price increase resulted in the increase in the
receivables of THB 43.28 million, due to the increase in prepayment for raw materials and machineries. Increase in financial assets of THB 506.09 million from investment in fixed deposit at financial
inventories of THB 30.72 million or 1% of the total assets, a slight increase of THB 2.47 million compared to the last year due to increase of packaging and raw material for restaurant business. o Investment in
increase in product sales volume of 8.15 percent and increase in raw material cost, salary and benefits of the employees, gas expenses and repair and maintenance expenses. Cost of services was Baht 216.88
both local subsidiaries and foreign subsidiaries, and repayment for long term borrowing. Increased in trade and other receivables of THB 52.88 million, due to the increase in sales and prepayment for raw
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
amounted of Baht 1,708.3 million in 2018, a 4.6% increase from 2017. The details have shown in the table below. (Unit: Million Baht) Revenue 2018 2017 % Change Industrial Water Sales 1,252.6 1,155.2 8.4% Raw
828 million due to: Trade accounts payable increased by Baht 398 million mainly due to increase of Baht 336 million from raw material trade payable for the Company. Current portion of long-term loan
the table below. Revenue Consolidated financial statements for the period 2Q2016 2Q2017 Increase /(Decrease) Baht million Baht million Baht million % Industrial Water Sales 257.5 281.1 23.6 9.2 Raw